Atropine is an alkaloid originally synthesized from Atropa belladonna. It is a racemic mixture of d-and l-hyoscyamine, of which only l-hyoscyamine is pharmacologically active. Atropine is generally available as a sulfate salt and can be administered by intravenous, subcutaneous, intramuscular, intraosseous, endotracheal and ophthalmic methods. Oral atropine ...
The intravenous, intramuscular, subcutaneous, intraosseous and endotracheal use of atropine is indicated for the temporary blockade of severe or life-threatening muscarinic effects. The intramuscular use of atropine in the form of a pen injector is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having cholinesterase act...
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, New Taipei City, Taiwan
University Medical Center Groningen, Groningen, Netherlands
Baskent University School of Medicine Adana Teaching and Research Hospital, Adana, Turkey
New York State Psychiatric Institute, New York, New York, United States
Women and Children's Hospital of Buffalo, Buffalo, New York, United States
Health Sciences Centre, Winnipeg, Manitoba, Canada
Diabetes research Division, Department of Internal Medicin, Gentofte Hospital, Hellerup, Denmark
Diabetes Research Division, Department of Internal Medicine, Gentofte Hospital, Copenhagen Denmark, Hellerup, Denmark
Gachon University Gil Medical Center, Incheon, Korea, Republic of
Texas Diabetes Institute - University Health System, San Antonio, Texas, United States
South Texas Veterans Health Care System, San Antonio, Texas, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.